Sökning: id:"swepub:oai:DiVA.org:liu-67153" >
Compilation of cost...
-
Eckard, NathalieLinköpings universitet,Utvärdering och hälsoekonomi,Hälsouniversitetet
(författare)
Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies
- Artikel/kapitelEngelska2011
Förlag, utgivningsår, omfång ...
-
2011-02-17
-
Informa Healthcare,2011
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-67153
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-67153URI
-
https://doi.org/10.3109/14017431.2011.557438DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:for swepub-publicationtype
Anmärkningar
-
Original Publication: Nathalie Eckard, Magnus Janzon and Lars-Åke Levin, Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies, 2011, Scandinavian Cardiovascular Journal, (45), 2, 72-76. http://dx.doi.org/10.3109/14017431.2011.557438 Copyright: Informa Healthcare http://informahealthcare.com/
-
Objectives. Despite the continuing interest in health economic research, we could find no accessible data set on cost-effectiveness, useful as practical information to decision makers who must allocate scarce resources within the cardiovascular field. The aim of this paper was to present cost-effectiveness ratios, based on a systematic literature search for the treatment of heart diseases. Design. A comprehensive literature search on cost-effectiveness analyses of intervention strategies for the treatment of heart diseases was conducted. We compiled available cost-effectiveness ratios for different heart conditions and treatment strategies, in a cost-effectiveness ranking table. The cost-effectiveness ratios were expressed as a cost per quality adjusted life year (QALY) or life year gained. Results. Cost-effectiveness ratios, ranging from dominant to those costing more than 1,000,000 Euros per QALY gained, and bibliographic references are provided for. The table was categorized according to disease group, making the ranking table readily available. Conclusions. Cost-effectiveness ranking tables provide a means of presenting cost-effectiveness evidence. They provide valid information within a limited space aiding decision makers on the allocation of health care resources. This paper represents an extensive compilation of health economic evidence for the treatment of heart diseases.
Ämnesord och genrebeteckningar
-
Cost
-
cost-effectiveness
-
rankings
-
heart disease
-
priority setting
-
evidence-based medicine
-
MEDICINE
-
MEDICIN
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Janzon, MagnusÖstergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken US(Swepub:liu)magja75
(författare)
-
Levin, Lars-ÅkeLinköpings universitet,Utvärdering och hälsoekonomi,Hälsouniversitetet(Swepub:liu)larle77
(författare)
-
Linköpings universitetUtvärdering och hälsoekonomi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Scandinavian Cardiovascular Journal: Informa Healthcare45:2, s. 72-761401-74311651-2006
Internetlänk
Hitta via bibliotek
Till lärosätets databas